MAPK1 and neoplasm: Molecularly, multiple integrin-dependent and cancer-related pathways (such as FAK, ERK/MAPK, Src, AKT and Ras) are activated as a result of increased β1 level, empowering promotion of tumor growth and treatment resistance [4].